(What’s Left of) Our Economy: U.S. Manufacturing’s Now Defying Hurricanes and Delta

Tags

aircraft, aircraft parts, appliances, Boeing, CCP Virus, chemicals, computer and electronics products, coronavirus, COVID 19, Delta variant, electrical equipment, fabricated metal products, facemasks, Federal Reserve, furniture, Hurricane Ida, inflation-adjusted growth, machinery, manufacturing, masks, medical devices, medicines, oil refining, paper, personal protective equipment, petrochemicals, pharmaceuticals, plastics, PPE, real output, semiconductor shortage, supply chain, travel, ventilators, Wuhan virus, {What's Left of) Our Economy

Domestic manufacturing’s done it again. Just as with the Labor Department’s August jobs report, the Federal Reserve’s new release on manufacturing output for the month shows that industry kept dodging whatever potholes the CCP Virus and its highly infectious Delta variant keep digging for the rest of the U.S. economy.

America-based manufacturers’ inflation-adjusted production grew by a meager 0.11 percent sequentially in August. But output was held down by facility closures forced by Hurricane Ida in the petrochemicals, plastics resins, and petroleum refining sectors. Overall revisions were mixed, but some upgrades and downgrades in individual major industries were pretty remarkable, as will be seen below.

The biggest winners in the new price-adjusted manufacturing production report were the small, catch-all “other manufacturing” category (2.42 percent); furniture and related products (up 2.07 percent); computer and electronics products (whose 1.21 percent output rise may have been a response to the worldwide shortage of semiconductors); paper (up 1.07 percent); and fabricated metal products (up 0.74 percent).

The biggest losers were electrical equipment, appliances, and components (down 1.16 percent); textiles products (down 0.81 percent on month); machinery (down 0.80 percent); and the big chemicals sector (down 0.49 percent).

Normally, the machinery results would be discouraging, since its products are used so widely both in the rest of manufacturing and also in big non-manufacturing industries like agriculture and construction. But its August dip followed a July jump of 3.31 percent – its best production improvement since January’s 4.63 percent – which was dramatically upgraded from the previously reported 1.91 percent.

The electrical equipment category followed a similar pattern. Its July real production results were revised all the way up from 2.31 percent to 3.95 percent – its best such performance since January, 2010, when the economy was still in its early bounce-back from the Great Recession that followed the global financial crisis.

Also enjoying a solid August were two narrower manufacturing categories that remain in the news due to the ongoing effects of the CCP Virus. Air travel has of course suffered throughout the pandemic-era, and aerospace manufacturing giant Boeing has been hit with numerous related manufacturing and safety problems (including some pre-dating the pandemic, like the grounding of the popular 737 Max jetliner).

Yet aircraft and parts production in constant dollars advanced by 0.34 percent in August, and in another major revision, July’s previously reported 2.78 percent increase is now pegged at 4.10 percent – its best such result since January’s 6.79 percent burst. And June’s downgraded 3.57 percent rise was bumped back up to 3.84 percent. As a result, aircraft and parts production is now 12.63 percent higher in after-inflation terms than in February, 2020 – the last full data month before the virus began significantly affecting the U.S. economy.

The pharmaceuticals and medicines sector (which includes vaccines) saw a real month-to-month production increase of 0.89 percent in August, and revisions were modest and mixed. These results left inflation-adjusted output 12.33 percent higher than its immediate pre-pandemic levels.

But August real production sank sequentially by 1.73 percent in the vital medical equipment and supplies sector – which includes virus-fighting items like face masks, protective gowns, and ventilators.

On the brighter side, July’s initially reported 1.71 percent constant dollar production rise was revised up to 2.42 percent. June’s dramatically downgraded 1.54 percent decrease was upgraded to a 0.13 percent drop, and May’s upwardly revised 1.86 percent real growth was downgraded only slightly – to 1.78 percent. Even so, on a price-adjusted basis, this crucial industry is just 2.66 percent larger than before the CCP Virus arrived in force.

Domestic industry still faces important headwinds of course – and not just from the possibility that Delta keeps worsening America’s public health and economy, and that approaching winter weather triggers a new wave of infections, hospitalizations, deaths, and restrictions. Those global supply chain snags are still with us, too.

But throughout the pandemic era, U.S.-based manufacturers have overcome obstacles just like this, and their consistent vigor indicates that it’s the pessimists about their future prospectswho now face the biggest burden of proof.

Glad I Didn’t Say That! A Claim that Masks Are and Aren’t Good for Kids.

Tags

CCP Virus, children, coronavirus, COVID 19, education, facemasks, Glad I Didn't Say That!, masks, mental health, psychology, schools, Wuhan virus

“[T]here is plenty of reason to believe that [mask wearing] won’t 

cause any harm” to children.

– Research psychologist Judith Danovitch, August 18, 2021

 

“This is not to say that masks are preferable to no masks, all things

being equal.”

– Research psychologist Judith Danovitch, August 18, 2021

(Source: “Actually, Wearing a Mask Can Help Your Child Learn,” by Judith Danovitch, The New York Times, August 18, 2021, Opinion | Actually, Wearing a Mask Can Help Your Child Learn – The New York Times (nytimes.com))

 

 

Im-Politic: Delta Fear is Leading The Science, Not Following It

Tags

Anthony S. Fauci, Biden, CCP Virus, Centers for Disease Control and Prevention, coronavirus, COVID 19, Delta variant, hospitalizations, Im-Politic, infections, lockdowns, masks, public health, vaccine passports, Wuhan virus

Sorry, but I’m not that comforted by the fact that Anthony S. Fauci is now saying  that “I don’t think we’re going to see lockdowns” because of the rapid spread of the Delta variant of the CCP Virus.

That’s because (1) President Biden’s top medical advisor has been such a single-minded backer of broad curbs on economic activity despite their devastating costs to both workers and businesses, not to mention the educational and non-virus public health crises they’ve worsened (like deaths from opioid overdoses); and (2) because he and the rest of the lockdown crowd keep harping on fatally flawed measures of virus dangers that have triggered previous lockdowns, and that are especially prominent and misleading because of Delta’s unusual transmissability. The two most important are case numbers and hospitalization increases.

Normally, the number of victims of a given disease and how that number’s been changing would be crucial gauges of the threat it poses to a population at large and of the effectiveness of mitigation steps already taken.

As has been known since the early phases of the pandemic, however, the CCP Virus can be present asymptomatically. That is, many individuals might not know they’re hosting it, either because they’re still feeling perfectly healthy, or because the effects are so mild that they’re judged not worth dealing with – or reporting to the health providers on which governments at all levels in the United States rely heavily for the virus data, and that form the basis for their policy responses.

As a result, literally no one knows how many Americans have been affected by the CCP Virus and, even more important, how that number has been changing. The same goes for the Delta variant. And therefore, literally no one knows the actual national health consequences of its virulence, and especially what percentage of those who have caught Delta are now or will become seriously ill, or have died or will succumb. Those are the Delta statistic — not simple numbers recorded instances of serious illness or mortality, however distressing they are on humanitarian grounds — that matter in assessing the peril posed by this strain, and in formulating responses whose net effects economically, socially, and health-wise aren’t worse than the disease/

To understand this distinction further, think about what’s known about Delta-related hospitalizations. The most accurate answer is “Very little so far in the way of hard data.” Indeed, as pointed out last week by the American Society for Microbiology, “Research is ongoing to determine if Delta infection is associated with increased hospitalization and death.” But that hasn’t prevented a pandemic of claims that it’s been a  primary driver of admissions lately. (See, e.g., here and here — among a gazillion other articles.)

Let’s assume, however, that the narrative is true. If so, since June 27 through the end of last week, when according to the Washington Post‘s very convenient virus tracker, the number of virus-hospitalized Americans hit its lowest level since the spring of 2020, the number of such patients has increased from 16,403 to 49,498 (through July 31), or 33,095. That sounds like a lot of hospitalizations, and the percentage gain (the numbers have nearly tripled), seems even worse. So Delta looks pretty dangerous, right? But again, what’s the context – that is, what’s the share of Americans infected with Delta who get seriously ill enough to get hospitalized?

As of two weeks ago, according to the U.S. Centers for Disease Control and Prevention (CDC), the new strain was responsible for just over 83 percent of all new American CCP Virus cases. That was up from just over 30 percent on June 19 – just about the time virus-related hospitalizations hit their latest bottom. From that time through the end of July, just under 1.352 million total new virus cases have been recorded. So assuming that over the entirety of this period, Delta variant cases made up about 75 percent of these, their total at comes to 1.014 million.

Let’s further assume, in sync with the evidence-free narrative, that all of the new hospitalizations can be blamed on Delta. This would mean that 3.26 percent of the total new Delta cases (that 33,095 figure) were serious enough to require hospital care. Does that number justify even thinking about new lockdowns, much less calling them (only sort of) unlikely?

But don’t forget the asymptomatic cases! According to a new CDC estimate, as of mid-2020, 83 percent of total virus cases in America were asymptomatic – i.e., not recorded. Since so much has changed then – mainly, mass vaccination – that 83 percent figure probably doesn’t hold any more. A reasonable guess might be that 33 percent is now more like it (since about half of the total population is now fully vaccinated and many more Americans have either natural or acquired immunity).

If that’s right, the number of new Delta strain infections is more like 1.5 million, not one million. And the hospitalization rate is more like 2.21 percent. So the notion that “the war [against the virus] has changed” because of this recent mutation, as contended by an internal federal health document obtained by the Washington Post, looks recklessly alarmist.

Further, such views look even wilder and crazier given the likelihood that Washington’s methods for defining cases and virus-related hospitalizations have produced seriously exaggerated counts.

After all, detecting the virus’ presence in an individual is only one of several sets of criteria that the CDC uses to conclude there’s a CCP Virus case to be counted. For example, for individuals that have been in contact with even a probable case of the virus, or who are members of designated vulnerable groups, a positive virus diagnosis can be justified if they display a headache and a sore throat at the same time. Or a sore throat and a runny nose. Or fatigue and a fever. Or if he or she is simply has a cough.

Even the CDC lab test standards for declaring a virus case via testing are dodgy, primarily because the main determinant seems to be the simple presence of the SARS-COV-2 pathogen that causes the disease. Unfortunately, these standards don’t seem to take into account how microorganisms like viruses can enter hosts and form “colonies” that result in no tissue infection and indeed don’t interact with the host at all. And as no less than the World Health Organization has pointed out, “Detection of viral RNA does not necessarily mean that a person is infectious and able to transmit the virus to another person.” Indeed, for all intents and purposes, it means that someone can be hosting the virus but shouldn’t be considered a case at all. One recent study suggests that this pattern is found in more than a tenth of positive cases.

Finally, the hospitalization numbers may be the least reliable of all. In the first place, the reporting system used by the CDC covers only about ten percent of the American population. Moreover, all you need to qualify for the CDC’s definition of a CCP Virus-related hospitalization is to be admitted into such a facility for any reason within 14 days of a positive test. As a result, if you need to be hospitalized for, say, cancer, and you’ve tested positive for the virus during the previous two weeks, you’re considered hospitalized for the CCP Virus.

It’s the same issue that the country has been dealing concerning whether various deaths are “from” or “with” Covid. And genuinely complicated judgment calls are involved. But for that very reason, public health officials should be awfully careful when they talk about devastating consequences of infections in and of themselves.

So the bottom lines are that the sharp recent increase in CCP Virus cases – including of course Delta variant cases – look overwhelmingly to be asymptomatic or mild; that even these numbers define positivity way too broadly, thus representing a major exaggeration and therefore affecting the nation’s health only marginally at best; and that, similarly, there’s probably even less even to true hospitalization rates that are already meager enough than meets the eye.

If Fauci, or anyone else in the Biden administration or in the ranks of restrictions fans had been pointing out any of these absolutely vital nuances since the virus’ Delta phase began, I’d have more faith in assurances about avoiding new lockdowns or any significant new business or behavior curbs. That they haven’t tells me that if such deeply mistaken and needlessly damaging (as known since the virus’ early period) measures aren’t yet on the lockdowners’ table, they’re not too far off — and so far, that would represent leading the science, not following it.  

(What’s Left of) Our Economy: Automotive’s Still in the U.S. Manufacturing Growth Driver’s Seat

Tags

aircraft, aluminum, appliances, automotive, CCP Virus, China, coal, coronavirus wuhan virus, COVID 19, Delta variant, electrical equipment, facemasks, Federal Reserve, industrial production, inflation-adjusted growth, inflation-adjusted output, infrastructure, lockdowns, machinery, manufacturing, masks, medical devices, metals, petroleum refining, pharmaceuticals, PPE, real growth, recovery, reopening, steel, stimulus, tariffs, Trump, vaccines, {What's Left of) Our Economy

Talk about annoying! There I was last Thursday morning, all set to dig into the new detailed Federal Reserve U.S. manufacturing production numbers (for June) in order to write up my usual same-day report, and guess what? None of the new tables was on-line! Fast forward to this morning: They’re finally up. (And here‘s the summary release.) So here we go with our deep dive into the results, which measure changes in inflation-adjusted manufacturing output.

The big takeaway is that, as with last month’s report for May, the semiconductor shortage-plagued automotive sector was the predominant influence. But there was a big difference. In May, domestic vehicles and parts makers managed to turn out enough product to boost the overall manufacturing production increase greatly. In June, a big automotive nosedive helped turn an increase for U.S.-based industry into a decrease.

The specifics: In May, the sequential automotive output burst (which has been revised up from 6.69 percent in real terms to 7.34 percent) helped push total manufacturing production for the month to 0.92 percent after inflation (a figure that’s also been upgraded – from last month’s initially reported already strong 0.89 percent). Without automotive, manufacturing’s constant dollar growth would have been just 0.47 percent.

In June, vehicle and parts production sank by an inflation-adjusted 6.62 percent , and dragged industry’s total performance into the negative (though by just 0.05 percent). Without the automotive crash, real manufacturing output would have risen by 0.40 percent.

Counting slightly negative revisions, through June, constant dollar U.S. manufacturing production in toto was 0.60 percent less than in February, 2020 – the economy’s last full pre-pandemic month.

Domestic industry’s big production winners in June were primary metals (a category that includes heavily tariffed steel and aluminum), which soared by 4.02 percent after inflation; the broad aerospace and miscellaneous transportation sector, which of course contains troubled Boeing aircraft, (more on which later), and which turned in 3.75 percent growth, its best such performance since January’s 5.62 percent pop; petroleum and coal products (up 1.36 percent); and miscellaneous durable goods, which includes but is far from limited to CCP Virus-related medical supplies (up 1.21 percent).

The biggest losers other than automotive? Inflation-adjusted production of electrical equipment, appliances, and components, which dropped sequentially by 1.73 percent in real terms; the tiny, remaining apparel and leather goods industry (1.44 percent); and the non-metallic minerals sector (1.07 percent).

Especially disappointing was the 0.55 percent monthly dip in machinery production, since this sector’s products are used so widely throughout the rest of manufacturing and in major parts of the economy outside manufacturing like construction and agriculture.

But in one of the biggest surprises of the June Fed data (though entirely consistent with the aforementioned broad aerospace sector), real output of aircraft and parts shot up by 5.24 percent – its best such performance since January’s 6.79 percent. It’s true that the May production decrease was revised from 1.47 percent to 2.61 percent. But with Boeing’s related and manufacturing and safety-related woes continuing to multiply, who would have expected that outcome?

And partly as a result of this two-month net gain, after-inflation aircraft and parts output as of June is 7.83 percent higher in real terms than in pre-pandemicky February, 2020 – a much faster growth rate than for manufacturing as a whole.

The big pharmaceuticals and medicines sector (which includes vaccines) registered a similar pattern of results, although with much smaller swings. May’s originally reported 0.22 percent constant dollar output improvement was revised down to 0.15 percent. But June saw a 0.89 percent rise, which brought price-adjusted production in this group of industries to 9.33 percent greater than just before the pandemic.

Some good news was also generated by the vital medical equipment and supplies sector – which includes virus-fighting items like face masks, face masks, protective gowns, and ventilators. Its monthly May growth was upgraded all the way up from the initially reported 0.19 percent to 1.18 percent. And that little spurt was followed by 0.99 percent growth in June.

Yet despite this acceleration, this sector is still a mere 2.27 percent bigger in real terms than in February, 2020, meaning that Americans had better hope that new pandemic isn’t right around the corner, that the Delta variant of the CCP Virus doesn’t result in a near-equivalent, or that foreign suppliers of such gear will be a lot more generous than in 2020.

As for manufacturing as a whole, the outlook seems as cloudy as ever to me. Vast amounts of stimulus are still being pumped into the U.S. economy, which continues to reopen and overwhelmingly stay open. That should translate into strong growth and robust demand for manufactured goods. The Trump tariffs are still pricing huge numbers of Chinese goods out of the U.S. market. And the shortage of automotive semiconductors may actually be easing.

But the spread of the Delta variant has spurred fears of a new wave of local and even wider American lockdowns. This CCP Virus mutation is already spurring sweeping economic curbs in many key U.S. export markets. Progress in Washington on an infrastructure bill seems stalled. And for what they’re worth (often hard to know), estimates of U.S. growth rates keep coming down, and were falling even before Delta emerged as a major potential problem. (See, e.g., here.)

I’m still most impressed, though, by the still lofty levels of optimism (see, e.g., here)  expressed by U.S. manufacturers themselves when they respond to surveys such as those sent out by the regional Federal Reserve banks (which give us the most recent looks). Since they’re playing with their own, rather than “other people’s money,” keep counting me as a domestic manufacturing bull.

(What’s Left of) Our Economy: A “Gentleman’s C” for the New Manufacturing Jobs Numbers

Tags

aircraft, aircraft engines, aircraft parts, automotive, Boeing, CCP Virus, electronics, Employment, fabricated metals products, facemasks, food products, furniture, housing, Jobs, Labor Department, manufacturing, masks, metals, pharmaceuticals, ports, PPE, printing, productivity, protective gear, recession, recovery, reopening, semiconductor shortage, tariffs, vaccines, {What's Left of) Our Economy

June’s gains weren’t nearly enough to overcome the latest trend in U.S. manufacturing employment: From a job growth leader earlier during the CCP Virus pandemic, domestic industry has turned into a laggard. It’s not lagging by a big margin, but given significant net headwinds it should still be enjoying, recent results are clearly disappointing.

This morning, the Labor Department reported that U.S.-based manufacturers created 15,000 net new jobs in June – a modest number given the 662,000 increase in total private sector employment on month. At least revisions were positive. May’s initially reported 23,000 monthly improvement is now judged to be 39,000, but April’s already downwardly revised 32,000 sequential job loss is now pegged at 35,000.

In many of the nation’s supposedly prestige colleges, the grade earned by this kind of result would be called a “Gentleman’s C.”

As a result, domestic manufacturing has now regained 904,000 (66.32 percent) of the 1.363 million jobs lost during the pandemic. The numbers for the private sector overall are 72.98 percent of the 21.353 million lost jobs that have been recovered, and for the total non-farm economy (the definition of the American employment universe used by the U.S. government, which includes government jobs) 69.75 percent of the 22.362 million jobs lost.

A manufacturing optimist (and I’ve been one of them) can note that industry took less of an employment hit during the pandemic-loss months of March and April, 2020. Manufacturing employment sank by 10.65 percent, versus 16.46 percent for the private sector and 14.66 percent for the whole non-farm economy.

But nowadays, domestic manufacturers are still benefiting from major tariffs plus massive government stimulus on both the fiscal and monetary fronts, and from the huge ramp up in vaccine production. Reopening-related bottlenecks clearly are causing problems, but according to the major national surveys that measure how manufacturers themselves believe they’re faring, production and new orders for their products keep growing strongly. (For the newest ones, see here and here.) Even given equally widespread reports that new workers are hard to find, I expected hiring to remain much more robust than it has.

One explanation may be higher productivity, which enables businesses to turn out more goods with fewer workers. But given the longstanding difficulties of gauging this measure of efficiency, and undoubted pandemic-era distortions, I’m reluctant to put too much stock in this argument.

The shortages issues have been once again illustrated by the dominance of the automotive sector in the June manufacturing jobs picture. Payrolls of vehicles and parts companies fell by 12,300 – the biggest individual sector decreases by far – and surely stem from the continuing global shortage of the computer chips that have become ever more important parts of cars and trucks of all kinds.

One small bright spot in the June figures – the 300 jobs increase in the machinery sector. It’s an important indicator of the overall state of industrial hiring, since its products are used throughout industry (as well as in non-manufacturing sectors like agriculture and construction). At the same time, these new positions represented machinery’s weakest sequential performance since January’s 3,200 employment decrease.

Other big June manufacturing net hiring winners were furniture and related products (up 8,500, no doubt reflecting still strong home sales and remodeling activity), fabricated metals products (up 5,700, which is noteworthy given still widespread whining about the ongoing U.S. tariffs on metals), and miscellaneous durable goods manufacturing (up 3,300 – encouraging since this category includes many pandemic-related medical supplies).

The biggest losers other than automotive were food products (down 4,100 and continuing an employment slump that began in January), electronic instruments (down 2,100 and possibly related to the semiconductor shortage), and printing and related activities (down 1,400).

Pandemic-related industries turned in a mixed hiring performance, according to the latest jobs report. Job creation accelerated significantly in the surgical appliances and supply sector, which contains protective gear like face masks, gloves and surgical goans. Its payrolls grew by 1,700 on month in May (its data are one month behind, as is the case with the other sectors examined below), up from April’s 1,200 and its best monthly total since last July’s 3,000. This surgical category’s workforce is now 11.50 percent bigger than in February, 2020 – the last pre-pandemic month.

But the May figures revealed a job creation setback in the overall pharmaceuticals and medicines industry. April’s hiring was revised down slightly, from 2,700 to 2,500, but the number was still solid. In May, however, its payrolls shrank by 400, its worst such performance since pandemicky April, 2020. And its workforce is only 3.82 percent greater than in February, 2020.

Better news came out of the pharmaceuticals subsector containing vaccines, but not that much better. This industry added one thousand workers on net in May, but April’s initially reported 1,300 jobs increase was revised down to 1,100. Still, this vaccines-heavy sector now employs 9.20 percent more workers than just before the pandemic.

And in aircraft, Boeing’s continuing manufacturing and safety issues surely helped produce this industry’s worst jobs month – consisting of a 5,500 payroll decrease – since June, 2020’s 5,800. This sector has now lost 9.39 percent of its jobs since the final pre-pandemic month.

Interestingly, the aircraft engines and parts, and non-engine parts categories weren’t nearly as hard-hit job-wise in May. (The former even maintained employment levels.) But payrolls in each are down since February, 2020, by roughly twice as much proportionately as in aircraft.

Major uncertainties still hang over the domestic manufacturing jobs scene, and in one important respect – big new backups in Chinese ports – they’ve become murkier. Nor do Boeing’s problems seem ready to end any time soon. I’m still bullish on U.S.-based manufacturing’s employment outlook, at least in the short and medium terms mainly because American policy remains so overwhelmingly stimulative and its effects are still coursing through the economy. But I’m getting a little impatient for the numbers to start backing me up once again.

(What’s Left of) Our Economy: Springtime Blahs for U.S. Manufacturing Jobs

Tags

aerospace, aircraft, appliances, automation, automotive, Boeing, CCP Virus, coronavirus, COVID 19, Employment, fabricated metal products, Jobs, Labor Departent, machinery, manufacturing, masks, metals tariffs, non-farm business, non-farm payrolls, pharmaceuticals, PPE, productivity, protective gear, regulatory policy, tariffs, tax policy, vaccines, Wuhan virus, {What's Left of) Our Economy

In contrast to the mixed set of signals I saw being given off by last month’s official monthly U.S. jobs report (for April), today’s May figures are pretty clearly indicating that manufacturing hiring is in a weak patch. In fact, the patch has been weak enough to turn the sector from a national employment creation leader to a laggard. Just as important, the short-term outlook at least seems somewhat dimmer than it had been.

The main reason for confusion over the previous data had to do with the disconnect between the automotive-heavy losses of April (which accounted for more than all of that month’s initially reported 18,000 net job decrease) and the positive revisions for the preceding months. Another very encouraging sign – the second straight month of strong jobs gains for the machinery sector, whose products are used widely not only in the rest of manufacturing, but in other major parts of the economy like agriculture and construction.

May’s results were almost a mirror image – and not in a good way.

For example, whereas in April, the 27,000 sequential automotive job losses exceeded total manufacturing job loss of 18,000 (leaving the rest of industry’s hiring performance pretty subdued, to be sure), in May, automotive payrolls rose by 24,800. But overall manufacturing job gains totaled only 23,000 – so the rest of the sector shed workers on net.

In addition, revisions are now negative. April’s manufacturing employment is now judged to have fallen by 32,000 month-to-month, not 18,000. That’s largely because that month’s automotive layoffs were much bigger than first reported – 37,700 rather than 27,000. Even March’s very good upwardly revised monthly hiring surge of 54,000 has now been revised down again to 51,000.

As for machinery, that crucial industry lost 4,700 jobs on net in May – its worst results by far since April, 2020 – at the depths of the CCP Virus-induced downturn and the first negative number since January. Moreover, this April’s 3,700 monthly jobs increase has now been revised down to 1,900, and March’s last upgraded 5,400 figure is now pegged at only 3,500.

In all, manufacturing has now regained 876,000 (64.27 percent) of the 1.363 million jobs it lost at the pandemic’s height in the spring of 2020. That’s now well behind the 69.74 percent employment recovery of the private sector and even the 65.88 percent rebound of the total economy (defined as the non-farm sector by the U.S. Labor Department, which compiles and categorizes the data).

The manufacturing sectors with the biggest sequential May jobs gains were the overall transportation equipment sector (where a 9,000 hiring improvement was propped up by the automotive increases), miscellaneous non-durbable good makers (up 4,100), fabricated metals products (up 3,500) miscellaneous durable goods manufacturing (a catch-all category including everything from surgical equipment – like facemasks and other personal protection equipment to gaskets to jewelry – where payrolls were up 3,400), and computer and electronics products and electrical equipment and appliances (up 2,800 each).

The hiring in fabricated metals and appliances was noteworthy given that companies in both industries have been complaining loudly about the pain they’ve been suffering from higher metals prices stemming in part from ongoing U.S. tariffs on these materials. (See, e.g., here and here.)

May’s big manufacturing jobs losers aside from machinery were non-metallic mineral products (down 2,200), paper and paper products (down 2,100), and the big chemicals sector, which is another big supplier of a wide variety of products to the entire economy (down 1,100).

More encouragingly, when it comes to industries closely related to the fight against the pandemic, job creation seems picking up, although the relevant data are one month behind the rest of the jobs figures. Specifically, in the surgical appliances and supplies sector that includes the protective gear, March’s employment increase was unrevised at 900, and hiring accelerated to 1,200 in April – the best monthly performance since September’s 1,600. This sector’s payrolls are now 10,400 (9.89 percnt) higher than in February, 2020 – the last pre-pandemic month.

For pharmaceuticals and medicines overall, March’s 1,500 sequential jobs increase was revised up to 1,600, and April hiring surged to 2,700 – its best performance by far of the CCP Virus period. Its payrolls are up by 12,500 (4.01 percent) since pre-pandemicky February, 2020.

For the pharmaceuticals subsector containing vaccines, March’s initially reported employment increas of 500 is now judged to be 800, and net hiring grew by 1,300 in April – a solid improvement by this industry’s recent standards. As a result, its workforce has now increased by 9,200 (9.30 percent) since February, 2020.

The same unfortunately can’t be said for the aerospace industry, and continuing and even mounting troubles for Boeing presage ongoing woes for the foreseeable future. March’s initially reported 1,800 monthly job loss for aircraft has now been revised for the worse to 1,900, and the sectors workforce fell by another 200 in April. Meanwhile, following sequential March losses in aircraft engines and parts, and in non-engine aircraft parts, employment flatlined in these two sectors combined in April.

Continued strength in the overall recovery of the U.S. economy should provide strong tailwinds for domestic manufacturers and for industry’s jobs figures, and continuing tariffs should help by keep much foreign competition (especially from China) out of the market.

Vaccine production will likely keep expanding – and requiring more workers – as well, mainly to supply immense foreign demand. But the sector is so small that its employment performance can’t move the manufacturing jobs needle much.

Boeing’s problems, however, can be expected to cast a big shadow not only over the big aerospace industry, but over its big domestic supply chain as well. And although the global semiconductor shortage that has hit the automotive sector especially hard may be starting to ease, the damage appears likely to take considerably longer to overcome. Manufacturers face big questions about the future of U.S. tax and regulatory policy, too.

Recently, moreover, some data’s come out pointing to a development that might wind up strengthening domestic industry in toto, but weakening its employment potential, at least in the short run. Labor Department figures show that, from the depths of the pandemic through the first quarter of this year, U.S.-based manufacturing has boosted its labor productivity much faster than the non-farm economy generally — and much faster than it has since its recovery from the last recession.  In other words, manufacturers lately been improving their ability to turn out product more than they’ve increased hiring. 

Whether this is a secular change or whether industry will revert to its recent mean is anyone’s guess. Also highly uncertain is whether better productivity growth (including of course more use of labor-saving technologies) will wind up destroying jobs on net, or increasing them by supercharging production. So far history seems to teach that such advances are net employment creators, but is that inevitable going forward? And is it inevitable for manufacturing specifically? All I can say is “Stay tuned” and “Be patient.”          

Im-Politic: Our Dysfunctional Watchdog of Democracy

Tags

Anthony S. Fauci, Barry Meier, Biden, Buzzfeed.com, CCP Virus, coronavirus, COVID 19, democracy, Donald Trump, facemasks, Im-Politic, journalism, lockdowns, Mainstream Media, masks, Russia, Steele dossier, The New York Times, The Washington Post, Thomas Jefferson, Trump-Russia, Wuhan virus, Yellow journalism

A New York Times article posted this past weekend strongly reinforces a suspicion that I’ve held for some time about the title of most worrisome – because largely neglected – existing threat to American democracy. It’s not demagogues who get elected to high (or even the highest) public office. It’s not white supremacists or Antifa. It’s not voter fraud or voter suppression. It’s not Russian leader Vladimir Putin. It’s not even the kind of disinformation and misinformation and even election interference that he and other foreign dictators (like China’s Xi Jinping) have engaged in.

Instead it’s our own Mainstream Media – including the gargantuan social media platforms that have come to play such a huge role in determining what news Americans see, watch, and hear.

Why are these news organizations so dangerous? For two main reasons. First, their democracy-subverting activities are much more subtle and therefore harder to identify than those of the above culprits. Second, their ever-growing partisanship and arrogance is destroying what has long been relied on as the nation’s fail-safe mechanism – a watchdog press.

To be fair, this idea has always been problematic, even though throughout U.S. history, prominent Americans have made statements like “Our liberty depends on the freedom of the press, and that cannot be limited without being lost” (Thomas Jefferson) and “Democracy Dies in Darkness” (the Washington Post).

Yes, despite the bedrock Constitutional system of separation of powers, it’s been essential for some influential force outside government to “guard the guardians.” But embedded in the very consequent need for private ownership (to ensure that the press can independently monitor the government) is the danger that these owners will solely or mainly use their power to further their own particular interests, not society’s.

All of which is to say that we’ve long had a national conundrum to deal with. But it doesn’t seem unreasonable to conclude that, once journalism clearly exited its sensationalistic “Yellow” phase and (probably in the years following Wold War II), started acting like a profession that needed to embody and uphold standards of accuracy and objectivity, the major media met its watchdog responsibilities fairly well – over both government and the private sector.

What the author of the Times piece, former journalist Barry Meier, makes clear, is that there’s not only more reason than ever to fear that the commitment to objectivity is rapidly weakening (and these fears have been amply justified lately, as I’ve reported here). There’s also more reason than ever to fear that the kind of commitment to accountability watchdogs must accept – inevitably entailing an acknowledgement of legitimate outside criticism and the imperative of correcting mistakes – seriously is fading as well.

These worries have been triggered by two specific observations made by Meier about the Mainstream Media’s handling of the charges that former President Trump colluded with Russia to ensure victory in the 2016 election. As Meier recounts, these accusations were supercharged by reports that a former British super-spy had uncovered evidence that Trump’s personal misbehavior had exposed him to Russian blackmail, and resulted in his turning into a latterday Manchurian Candidate who would be forced to do Moscow’s bidding.

The infamous “Steele dossier” that supposedly made this case was published by a website called Buzzfeed.com in January, 2017 – shortly before Trump’s inauguration – and although no serious efforts at confirmation or even finding any supporting evidence were made, “countless articles, television shows, books, tweets and blog posts about it appeared.” (The dossier also formed part of the basis of the FBI’s request to a special U.S. court to spy on the Trump campaign in 2016, and Bureau Director James Comey’s March, 2017 disclosure that this investigation was continuing poured additional fuel on the Trump Russia fire.)

By 2019, Meier goes on, the Steele dossier had been exposed as a bogus hatchet job. But by that time, of course, the collusion firestorm had dominated the Trump presidency, along with equally offbase news coverage of his administration, and surely compromised its ability to govern effectively.

Why this prolonged media focus? In large measure, as Meier explains, because “It was easy for many journalists to believe that Mr. Trump would do anything to win, even — given his stance with…Putin — collude with Russia.” Indeed, as the author observes, they picked up this ball and ran with it even though “Steele said that his information needed to be confirmed….”

This flagrant anti-Trump bias was bad enough. Much worse, though was the media’s response once the dossier had been debunked. In Meier’s words:

“[A] few reporters who had written about the dossier had backed away from it. ‘Some people have wanted to maintain that the dossier is checking out when, as far as I can tell, it hasn’t,’ said Michael Isikoff of Yahoo News. He was in the minority. When Erik Wemple of The Washington Post wrote a series of columns about the media infatuation with the dossier, most journalists he contacted either defended their work or ignored his inquiries.”

Even though Meier, Isikoff, and Wemple all work for Mainstream Media organizations themselves, these revelations are more disturbing because they cast doubt on these news organization’s willingness, either individually or collectively, to admit that a major preoccupation of theirs that shaped American politics for years was an utter crock. And in a similar vein, they’re grounds for great skepticism that these same media will produce accurate post-mortems on the actual actions by governments or by individual politicians that conformed with this Get Trump obsession.     

The reason for this reluctance is obvious: Their credibility – their most precious asset, even in this hyperpartisan era – would be devastated. But if these powerful companies won’t self-correct or correct the records of others – and in some systematic, comprehensive way that can make a difference, not in dribs and drabs – especially on a matter of this importance, then their watchdog reputation gets thrown out the window.

And as far as I’m concerned, good riddance. But if the big national media can’t be relied on to play this role responsibly, who or what can? And can a democracy worthy of the name long survive without actors that can credibly set the record straight before the archives are fully open to historians years and even decades from now?

Moreover, we’re getting an example of how such flawed Mainstream Media performance could be a literally fatal flaw – and on mass level.  Specifically,  evidence has appeared throughout the CCP Virus pandemic that sweeping lockdown- and mask-wearing-centric mitigation strategy pursued in most of the country at the behest of the public health establishment was completely and tragically mistaken. (See, e.g., here.)  America’s major national news organizations have obviously bought in to the stay-at-home and mask-up claims, as shown, for example, by their near canonization of leading lockdowns proponent Dr. Anthony S. Fauci, the federal government’s head immunologist and now President Biden’s top medical adviser. 

I’d like to believe that if conclusive evidence emerges invalidating this virus-fighting approach, and supporting measures with potentially greater effectiveness during future pandemics, the news would be trumpeted all over the Mainstream Media even if the federal government tried to hush it up.  But as of now, expressing the hope that the real story might become known looks like nothing so much as practicing quackery.  

Im-Politic: Texas-Sized Goofs from the Experts on the Lockdowns

Tags

Anthony S. Fauci, Biden, CCP Virus, coronavirus, COVID 19, facemasks, Im-Politic, lockdowns, mask mandate, masks, Mississippi, reopening, social distancing, Texas, Washington Post, Wuhan virus

This is getting embarrassingly easy. The so-called experts along with control freak politicians keep making apocalyptic predictions about decisions at any level of government in the United States to relax CCP Virus-related curbs on personal behavior and business activity. And they keep getting it laughably wrong. The latest example: Texas’ decisions last month to reopen its economy fully and lift its state-wide mask mandate, both effective March 10, and similar announcements by Mississippi effective March 3.

The blowback was swift and harsh. Dr. Anthony S. Fauci, longtime director of the federal government’s National Institute for Allergy and Infectious Diseases and President Biden’s chief medical adviser, on March 3 attacked the moves as “quite risky.” And citing a recent plateauing of new infections in both states, added “That’s a dangerous sign because when that has happened in the past, when you pull back on measures of public health, invariably you’ve seen a surge back up.”

Mr. Biden was much blunter, contending on the same day that both states were making “a big mistake” that stemmed from “Neanderthal thinking.”

Well now it’s a little more than a month later and it sure looks like the know-nothings are in Washington, D.C. As of yesterday, according to the Washington Post‘s virus tracker, the seven-day average of daily new reported cases in Texas is down by 40.60 percent since March 10, and in Mississippi it’s plunged by 61.37 percent since March 3.

Even more revealing, while reported infections in these troglodyte states were sinking, guess what happened to reported cases nationally? Between March 3 and yesterday, the seven-day new infections average rose by two percent. And needless to say, this nation-wide figure includes many states that have retained mask mandates and other extensive behavior and economic curbs.

By the way, I’m fully aware that case numbers are a deeply flawed measure of pandemic spread and progress against it, due to flaws in states’ reporting systems, varying definitions of “case,” the undoubtedly large numbers of asymptomatic infections throughout the country, and now, surging numbers of vaccinations. I’m also aware that we’re now dealing with different strains of the virus with differing degrees of virulence.

But reported new infections are one of measures emphasized by Fauci in particular. And it seems safe to assume that he and the President know about the different strains. So live analytically by the chosen statistic, and die by it.

I’m also aware that neither Texas nor Mississippi was turning its back totally on the mitigation measures stressed by the Feds. For example, the former exempted areas “with high hospitalizations,” and those counties are entirely free to retain or impose significant restrictions. And businesses all over the state can still require mask-wearing and other hygiene measures.

Mississippi also still mandates mask-wearing where its not possible to follow its remaining social distancing rules (which are still noteworthy, especially in schools and for their extracurricular activities – including sporting events – at all levels, from kindergarten through university). Further, counties and municipalities are fully free to adopt stricter rules if they wish except for businesses providing essential services.

But Fauci and the President surely read the actual Texas and Mississippi executive orders – didn’t they?

It’s entirely possible that in the coming days and weeks, states that start or keep easing anti-virus mandates of all kinds will see rising case numbers. In fact, that appears to be the situation in Michigan now – even though its rules are still pretty restrictive. But actually, that’s the point. If comparable masks and lockdowns etc policies and comparable policy changes are producing dramatically different results, then clearly something, or some things, other than these restrictions and their status are mainly responsible. And recognizing this logic is crucial given that the economic curbs haven’t exactly been cost-free either in terms of the economy or public health.

For the time being, though, there’s one dimension of the CCP Virus story that seems firmly established. For the experts and the political leaders who profess to be simply “following the science” on pandemic forecasts, being whoppingly off-base means never having to say you’re sorry.

(What’s Left of) Our Economy: Winter Smacks February U.S. Manufacturing Output but Forecast Remains Bright

Tags

aerospace, aircraft, American Rescue Plan, automotive, Biden, Boeing, CCP Virus, China, coronavirus, COVID 19, Covid relief, Donald Trump, facemasks, Federal Reserve, industrial production, inflation-adjusted output, machinery, manufacturing, masks, medical equipment, petroleum refining, pharmaceuticals, plastics, PPE, real growth, resins, semiconductor shortage, semiconductors, stimulus package, tariffs, Texas, Trade, vaccines, winter, Wuhan virus, {What's Left of) Our Economy

Count me as one awfully surprised blogger when I saw this morning’s Federal Reserve U.S. manufacturing production figures (for February), which reported a 3.12 percent sequential drop in industry’s inflation-adjusted output. That was by far the worst such monthly performance since pandemicky April’s 15.83 percent crashdive, and even though the Fed largely blamed harsh winter weather in much of the country, it still contended that manufacturing would have shrunk by about half a percent even in balmier conditions.

A big reason for my surprise was the apparent contrast between these results and the findings of the monthly manufacturing surveys conducted by various of the Fed’s regional branches. They’re soft data, presenting manufacturers’ perceptions rather than actual changes in output (or jobs, or capital spending, or any other indicator), and I’ve written before that soft data are anything but perfect. But not only were the production reads in these surveys strong. They were strong even in Texas, where the storms were so severe. (And the Dallas Fed’s survey was conducted as they were raging.) Moreover, the same held for the February results from the neighboring Kansas City Fed bank.

Further, other hard data – specifically, on jobs – pointed to a good February for manufacturing, too, as industry expanded its payrolls by 21,000.

But the new Fed production numbers shouldn’t be dismissed entirely, so let’s look at the…lowlights, starting with the revisions, which were moderately negative. January’s previously reported 1.04 percent monthly advance is now pegged at 1.29 percent. December’s already once-downgraded inflation-adjusted output growth was lowered again, from 0.94 percent to 0.84 percent. November’s result, which had been upgraded twice (most recently to 1.10 percent) is now judged to have been 1.05 percent. October’s string of upward revisions was stopped, too, as the new report reveals a downgrade from 1.51 percent to 1.39 percent.

Overall, these readings mean that domestic manufacturing’s after-inflation production has grown by 20.26 percent since its April nadir, and stands 3.83 percent below its last pre-pandemic reading, from February.

As not the case with recent Fed industrial production reports, the output changes were highly concentrated in a few industries. Bearing out the central bank’s observation that “some petroleum refineries, petrochemical facilities, and plastic resin plants suffered damage from the deep freeze and were offline for the rest of the month,” most of these sectors saw outsized price-adjusted month-to-month drops in February. For petroleum and coal products, the fall-off was 4.43 percent, and for the huge chemicals sector, 7.11 percent Interestingly, the chemicals decline was even bigger than that it suffered last April, at the depths of the pandemic and related economic activity curbs (6.08 percent).

And as for those resin plants? Their February real output plummeted by fully 28.12 percent – much more than at any time last spring, during the pandemic’s height, and the worst such performance since the 30.64 percent cratering during Great Recessionary September, 2008. In fact, constant dollar output in the industry sank to its lowest level since equally Great Recessionary March, 2009.

Another February real production decrease that looks temporary (but perhaps longer-lasting): the 8.26 percent plunge in constant dollar automotive production. The main culprit is no doubt a global shortage of semiconductors that could well weigh on the entire domestic manufacturing sector going forward.

As known by RealityChek regulars, the machinery sector is a major barometer of manufacturing’s overall health, because its products are used throughout industry. So given February’s poor results for the entire sector, it’s no surprise that real machinery output was off by 2.33 percent on month. But January’s results were upgraded tremendously – from 0.52 percent after-inflation growth to 2.59 percent. So price-adjusted machinery output is still within 1.17 percent of its final pre-pandemic levels.

Because Boeing’s protracted safety-related problems continue to clear up, aircraft and parts production notched another month of growth in real terms in February – an increase of 1.04 percent. Revisions, however, were negative, especially December’s – its previously upgraded production increase (to a strong 3.03 percent) is now judged to be a 0.61 percent decline. Largely as a result, inflation-adjusted output is now just fractionally above its February pre-pandemic level.

The picture was brighter in pharmaceuticals and medicines. This industry, which includes vaccines, saw its after-inflation production climbed by anorther 1.29 percent in February. Moreover, January’s initially reported robust 2.42 percent increase was revised to an even better 2.57 percent. As a result, pharmaceutical and medicines real output is now 5.62 percent higher than just before the pandemic, and should generate even better results in the coming months, as vaccine production will be surging even more strongly.

Unfortunately, the also vital medical equipment and supplies sector – which includes virus-fighting items like face masks, face masks, protective gowns, and ventilators – is still behind the curve. Constant dollar production actually dipped by 0.56 percent on month in February, although in another major revision, January’s performance is now judged to be a 1.08 percent gain rather than a 0.54 percent loss. All the same, real production in this sector (which encompasses many other products as well) is still 1.37 percent less than just before the CCP Virus and the lockdowns arrived in force.

All told, I’m still full of confidence about domestic manufacturing production, due to the Boeing, vaccines, and now the Biden stimulus effects. And don’t forget the administration’s continued reluctance to lift its predecessor’s towering and sweeping tariffs on China, and on metals imports from many countries. Lastly: The weather’s bound to keep getting better!

(What’s Left of) Our Economy: U.S. Manufacturing Hiring Climbs Back on Track

Tags

aerospace, automotive, Biden, Boeing, CCP Virus, China, coronavirus, COVID 19, Donald Trump, gloves, healthcare goods, Jobs, macinery, manufacturing, masks, non-farm jobs, pharmaceuticals, PPE, private sector, semiconductor shortage, semiconductors, tariffs, transportation equipment, vaccines, Wuhan virus, {What's Left of) Our Economy

As this morning’s February official U.S. jobs report was dominated by a reopening-fueled surge in leiure and hospitality payrolls (which accounted for 355,000 of the month’s total 379,000 sequential improvement), American domestic manufacturing’s employment performance resumed chugging along.

U.S.-based industry gained 21,000 jobs on net last month, recovering from its drop off in January (which was revised down from a decline of 10,000 to one of 14,000). December’s initially reported advance, though, was upgraded from 31,000 to 34,000.

The February results mean that manufacturing has now regained 60.45 percent (824,000) of the 1.363 million jobs lost during the peak CCP Virus lockdowns period of last March and April. Consequently, they show that industry’s reemployment pace has continued to reverse its previous performance as the economy’s pandemic recovery leader.

That status now belongs to the overall private sector, which since last April has regenerated 62.61 percent (13.267 million) of the 21.191 million jobs it shed last spring.

Nonetheless, since public sector net hiring remains very weak, manufacturing’s job-creation performance remains well ahead of that of the economy as a whole – which is viewed by the Labor Department, which compiles and releases these statistics, as the “non-farm sector.” Since April, employment in this combined public and private sector is back up by 12.887 million – representing just 57.63 percent of the 22.362 million jobs they lost together in March and April.

Manufacturing’s biggest February jobs winner by far was transportation equipment (up 9,700 – more than 46 percent of industry’s total employment advance). Since payrolls in the very big automotive sector inched up by just 1,000, it’s likely that much of the rest of the increase came in an aerospace sector whose employment troubles are being healed by Boeing’s comeback from safety woes. But because the aerospace (and other non-automotive transportation) jobs figures are reported one month late, we’ll need to wait until the March report to know for sure.

Other major February manufacturing jobs gainers were miscellaneous non-durable goods (up 4,100), machinery (3,800), plastics and rubber products (3,000) and miscellaneous durable goods (2,800). The increases in miscellaneous non-durables and machinery were especially encouraging, as the former category (as detailed below) includes many of the medical goods vital to the anti-virus fight, and the latter’s products are used throughout not only the manufacturing sector, but other big parts of the economy like construction and agriculture.

The biggest February manufacturing jobs losers were food manufacturing (where payrolls fell by a net 3,100), non-metallic mineral products (2,400), and printing and related support activities (1,700).

Given the continuing struggle against the pandemic, the continuing shortages of many vital products like protective gear, and the surge in vaccine production, the jobs performance of healthcare goods once again underwhelmed – though keep in mind that, as with the non-automotive transportation goods categories, the data here are one month behind, too.

In the broad pharmaceuticals sector, employment actually fell by 700 in January. December’s initially reported 2,200 jobs rise has now been upgraded to 2,300, but this big industry’s payrolls are up just 1.89 percent since last Febuary – the last full pre-pandemic data month.

Hiring was stronger in the pharmaceuticals subsector containing vaccines. January employment rose by just 100 sequentially, but the initially reported December 1,100 payrolls increase was revised up to 1,600. As a result, the subsector’s workforce is now 4.55 percent bigger than last February.

The manufacturing category containing personal healthcare-related protection devices (PPE) like facemasks, gloves, and medical gowns has grown employment most impressively of all these healthcare sectors. But it lost 800 net new jobs in February, a drop that failed to offset the upward revisions of 600 for December. These shifts left employment in this sector 7.98 percent higher than the final pre-pandemic monthly figure.

Notwithstanding January’s workmanlike result, all the pieces still seem to be in place for an accelerating manufacturing jobs rebound: the return of normal economic conditions generally (however choppily), Boeing’s brightening prospects, the continuing need for much more in the way of vaccines and other medical goods, the Biden administration’s stated determination to boost domestic output of CCP Virus-related products, and last – but surely not least – the sweeping tariffs placed by the Trump administration on imports from China that for the near future President Biden apparently will keep.

No one should forget, though, that one strong new headwind has appeared – a global shortage of semiconductors that is already depressing production across manufacturing. Yet even this disruptive event at bottom seems largely due to the unexpected speed of the U.S. economic bounceback, especially in sectors shut down almost entirely, like automotive manufacturing. So whatever the short-term difficulties it causes, the microchip shortage looks like it stems from the kinds of problems, to borrow from an old sports adage, that manufacturing and its workers ultimately would like to have.